Analyst Ratings For NASDAQ:IMGN – ImmunoGen (NASDAQ:IMGN)
Today, HC Wainwright reiterated its Buy rating on NASDAQ:IMGN – ImmunoGen (NASDAQ:IMGN) with a price target of $18.00.
Some recent analyst ratings include
- 4/10/2018-HC Wainwright Reiterated Rating of Buy.
- 3/26/2018-Leerink Swann Reiterated Rating of Outperform.
- 10/12/2017-Jefferies Group Reiterated Rating of Buy.
- 8/30/2017-Canaccord Genuity Reiterated Rating of Buy.
- 8/29/2017-Cowen Reiterated Rating of Hold.
Recent Insider Trading Activity For NASDAQ:IMGN – ImmunoGen (NASDAQ:IMGN)
NASDAQ:IMGN – ImmunoGen (NASDAQ:IMGN) has insider ownership of 6.51% and institutional ownership of 78.25%.
- On 3/16/2018 Daniel M Junius, Director, sold 25,000 with an average share price of $12.02 per share and the total transaction amounting to $300,500.00.
- On 3/15/2018 David Brannon Johnston, CFO, sold 10,000 with an average share price of $11.53 per share and the total transaction amounting to $115,300.00.
- On 2/21/2018 David Brannon Johnston, CFO, sold 21,060 with an average share price of $10.87 per share and the total transaction amounting to $228,922.20.
- On 2/21/2018 Mark J Enyedy, CEO, sold 67,717 with an average share price of $10.87 per share and the total transaction amounting to $736,083.79.
- On 2/21/2018 Richard J Gregory, VP, sold 34,486 with an average share price of $10.88 per share and the total transaction amounting to $375,207.68.
- On 2/20/2018 Daniel M Junius, Director, sold 25,000 with an average share price of $11.68 per share and the total transaction amounting to $292,000.00.
- On 2/13/2018 Daniel M Junius, Director, sold 46,667 with an average share price of $10.01 per share and the total transaction amounting to $467,136.67.
Recent Trading Activity for NASDAQ:IMGN – ImmunoGen (NASDAQ:IMGN)
Shares of NASDAQ:IMGN – ImmunoGen closed the previous trading session at 9.97 up +0.09 0.91% with 9.880000114440918 shares trading hands.